Influence of Friedreich Ataxia GAA Noncoding Repeat Expansions on Pre-mRNA Processing

American Journal of Human Genetics

Volumn 83, Issue 1, 2008, Pages 77-88

  Baralle, Marco ^a   Pastor, Tibor ^a   Bussani, Erica ^a   Pagani, Franco ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FRATAXIN; MESSENGER RNA PRECURSOR;

AMINO ACID SEQUENCE; ARTICLE; EUKARYOTIC CELL; EXON; FRIEDREICH ATAXIA; GENETIC CODE; HELA CELL; HUMAN; HUMAN CELL; HYBRID GENE; INTRON; PRIORITY JOURNAL; RNA PROCESSING; RNA SPLICING;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; EXONS; FRIEDREICH ATAXIA; GENES, REPORTER; HELA CELLS; HUMANS; INTRONS; IRON-BINDING PROTEINS; MODELS, GENETIC; PLASMIDS; RNA PRECURSORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TRINUCLEOTIDE REPEAT EXPANSION; TRINUCLEOTIDE REPEATS;

EUKARYOTA;

EID: 46149111652     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2008.06.018     Document Type: Article

References (62)

1. Pandolfo M. The molecular basis of Friedreich ataxia. Adv. Exp. Med. Biol. 516 (2002) 99-118
2. Harding A.E. Friedreich's ataxia: A clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104 (1981) 589-620
3. Pandolfo M., and Koenig M. Friedreich's ataxia. In: Wells R.D., and Warren S.T. (Eds). Genetic Instabilities and Hereditary Neuromuscular Diseases (1998), Academic Press, San Diego, CA 373-398
4. Campuzano V., Montermini L., Molto M.D., Pianese L., Cossee M., Cavalcanti F., Monros E., Rodius F., Duclos F., Monticelli A., et al. Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271 (1996) 1423-1427
5. Clark R.M., Dalgliesh G.L., Endres D., Gomez M., Taylor J., and Bidichandani S.I. Expansion of GAA triplet repeats in the human genome: Unique origin of the FRDA mutation at the center of an Alu. Genomics 83 (2004) 373-383
6. Durr A., Cossee M., Agid Y., Campuzano V., Mignard C., Penet C., Mandel J.L., Brice A., and Koenig M. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Engl. J. Med. 335 (1996) 1169-1175
7. Filla A., De Michele G., Cavalcanti F., Pianese L., Monticelli A., Campanella G., and Cocozza S. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am. J. Hum. Genet. 59 (1996) 554-560
8. Clark R.M., Bhaskar S.S., Miyahara M., Dalgliesh G.L., and Bidichandani S.I. Expansion of GAA trinucleotide repeats in mammals. Genomics 87 (2006) 57-67
9. Campuzano V., Montermini L., Lutz Y., Cova L., Hindelang C., Jiralerspong S., Trottier Y., Kish S.J., Faucheux B., Trouillas P., et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum. Mol. Genet. 6 (1997) 1771-1780
10. Gacy A.M., Goellner G.M., Spiro C., Chen X., Gupta G., Bradbury E.M., Dyer R.B., Mikesell M.J., Yao J.Z., Johnson A.J., et al. GAA instability in Friedreich's ataxia shares a common, DNA-directed and intraallelic mechanism with other trinucleotide diseases. Mol. Cell 1 (1998) 583-593
11. Bidichandani S.I., Ashizawa T., and Patel P.I. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am. J. Hum. Genet. 62 (1998) 111-121
12. Ohshima K., Montermini L., Wells R.D., and Pandolfo M. Inhibitory effects of expanded GAA.TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo. J. Biol. Chem. 273 (1998) 14588-14595
13. Sakamoto N., Chastain P.D., Parniewski P., Ohshima K., Pandolfo M., Griffith J.D., and Wells R.D. Sticky DNA: Self-association properties of long GAA.TTC repeats in R.R.Y triplex structures from Friedreich's ataxia. Mol. Cell 3 (1999) 465-475
14. *TTC repeats in intron 1 of the frataxin gene, inhibits transcription. J. Biol. Chem. 276 (2001) 27171-27177
15. *(TTC)n repeats at neutral pH. Nucleic Acids Res. 32 (2004) 1224-1231
16. *TTC triplet repeat expanded in Friedreich's ataxia impedes transcription elongation by T7 RNA polymerase in a length and supercoil dependent manner. Nucleic Acids Res. 28 (2000) 2815-2822
17. *(TTC)n repeats on RNA synthesis and stability. Nucleic Acids Res. 35 (2007) 1075-1084
18. Mifflin R.C., and Kellems R.E. Coupled transcription-polyadenylation in a cell-free system. J. Biol. Chem. 266 (1991) 19593-19598
19. Sisodia S.S., Sollner-Webb B., and Cleveland D.W. Specificity of RNA maturation pathways: RNAs transcribed by RNA polymerase III are not substrates for splicing or polyadenylation. Mol. Cell. Biol. 7 (1987) 3602-3612
20. McCracken S., Fong N., Yankulov K., Ballantyne S., Pan G., Greenblatt J., Patterson S.D., Wickens M., and Bentley D.L. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385 (1997) 357-361
21. Maniatis T., and Reed R. An extensive network of coupling among gene expression machines. Nature 416 (2002) 499-506
22. Proudfoot N.J., Furger A., and Dye M.J. Integrating mRNA processing with transcription. Cell 108 (2002) 501-512
23. Krasilnikova M.M., and Mirkin S.M. Replication stalling at Friedreich's ataxia (GAA)n repeats in vivo. Mol. Cell. Biol. 24 (2004) 2286-2295
24. Pollard L.M., Sharma R., Gomez M., Shah S., Delatycki M.B., Pianese L., Monticelli A., Keats B.J., and Bidichandani S.I. Replication-mediated instability of the GAA triplet repeat mutation in Friedreich ataxia. Nucleic Acids Res. 32 (2004) 5962-5971
25. Saveliev A., Everett C., Sharpe T., Webster Z., and Festenstein R. DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing. Nature 422 (2003) 909-913
26. Herman D., Jenssen K., Burnett R., Soragni E., Perlman S.L., and Gottesfeld J.M. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat. Chem. Biol. 2 (2006) 551-558
27. Greene E., Mahishi L., Entezam A., Kumari D., and Usdin K. Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia. Nucleic Acids Res. 35 (2007) 3383-3390
28. Cartegni L., Chew S.L., and Krainer A.R. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 3 (2002) 285-298
29. Fairbrother W.G., Yeh R.F., Sharp P.A., and Burge C.B. Predictive identification of exonic splicing enhancers in human genes. Science 297 (2002) 1007-1013
30. Pagani F., and Baralle F.E. Genomic variants in exons and introns: Identifying the splicing spoilers. Nat. Rev. Genet. 5 (2004) 389-396
31. Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72 (2003) 291-336
32. Faustino N.A., and Cooper T.A. Pre-mRNA splicing and human disease. Genes Dev. 17 (2003) 419-437
33. Buratti E., Brindisi A., Pagani F., and Baralle F.E. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: A functional link with disease penetrance. Am. J. Hum. Genet. 74 (2004) 1322-1325
34. Hui J., Stangl K., Lane W.S., and Bindereif A. HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats. Nat. Struct. Biol. 10 (2003) 33-37
35. Ule J., Stefani G., Mele A., Ruggiu M., Wang X., Taneri B., Gaasterland T., Blencowe B.J., and Darnell R.B. An RNA map predicting Nova-dependent splicing regulation. Nature 444 (2006) 580-586
36. Muro A.F., Caputi M., Pariyarath R., Pagani F., Buratti E., and Baralle F.E. Regulation of fibronectin EDA exon alternative splicing: Possible role of RNA secondary structure for enhancer display. Mol. Cell. Biol. 19 (1999) 2657-2671
37. Goina E., Skoko N., and Pagani F. Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant. Mol. Cell. Biol. 28 (2008) 3850-3860
38. Pagani F., Buratti E., Stuani C., and Baralle F.E. Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. J. Biol. Chem. 278 (2003) 26580-26588
39. Al-Mahdawi S., Pinto R.M., Varshney D., Lawrence L., Lowrie M.B., Hughes S., Webster Z., Blake J., Cooper J.M., King R., et al. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics 88 (2006) 580-590
40. Pagani F., Stuani C., Tzetis M., Kanavakis E., Efthymiadou A., Doudounakis S., Casals T., and Baralle F.E. New type of disease causing mutations: The example of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum. Mol. Genet. 12 (2003) 1111-1120
41. Caputi M., Casari G., Guenzi S., Tagliabue R., Sidoli A., Melo C.A., and Baralle F.E. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res. 22 (1994) 1018-1022
42. Cramer P., Caceres J.F., Cazalla D., Kadener S., Muro A.F., Baralle F.E., and Kornblihtt A.R. Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol. Cell 4 (1999) 251-258
43. de la Mata M., Alonso C.R., Kadener S., Fededa J.P., Blaustein M., Pelisch F., Cramer P., Bentley D., and Kornblihtt A.R. A slow RNA polymerase II affects alternative splicing in vivo. Mol. Cell 12 (2003) 525-532
44. de la Mata M., and Kornblihtt A.R. RNA polymerase II C-terminal domain mediates regulation of alternative splicing by SRp20. Nat. Struct. Mol. Biol. 13 (2006) 973-980
45. *TTC tracts to generate two independent supercoiled domains. J. Mol. Biol. 360 (2006) 267-284
46. Calado A., Kutay U., Kuhn U., Wahle E., and Carmo-Fonseca M. Deciphering the cellular pathway for transport of poly(A)-binding protein II. RNA 6 (2000) 245-256
47. Davies J.E., Sarkar S., and Rubinsztein D.C. Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation. Hum. Mol. Genet. 17 (2008) 1097-1108
48. Pellizzoni L., Lotti F., Maras B., and Pierandrei-Amaldi P. Cellular nucleic acid binding protein binds a conserved region of the 5′ UTR of Xenopus laevis ribosomal protein mRNAs. J. Mol. Biol. 267 (1997) 264-275
49. Spellman R., and Smith C.W. Novel modes of splicing repression by PTB. Trends Biochem. Sci. 31 (2006) 73-76
50. Tacke R., Tohyama M., Ogawa S., and Manley J.L. Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell 93 (1998) 139-148
51. Lavigueur A., La Branche H., Kornblihtt A.R., and Chabot B. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 7 (1993) 2405-2417
52. Taniguchi I., Masuyama K., and Ohno M. Role of purine-rich exonic splicing enhancers in nuclear retention of pre-mRNAs. Proc. Natl. Acad. Sci. USA 104 (2007) 13684-13689
53. Masuyama K., Taniguchi I., Okawa K., and Ohno M. Factors associated with a purine-rich exonic splicing enhancer sequence in Xenopus oocyte nucleus. Biochem. Biophys. Res. Commun. 359 (2007) 580-585
54. Masuyama K., Taniguchi I., Kataoka N., and Ohno M. SR proteins preferentially associate with mRNAs in the nucleus and facilitate their export to the cytoplasm. Genes Cells 9 (2004) 959-965
55. Miranda C.J., Santos M.M., Ohshima K., Smith J., Li L., Bunting M., Cossee M., Koenig M., Sequeiros J., Kaplan J., et al. Frataxin knockin mouse. FEBS Lett. 512 (2002) 291-297
56. Chang J.G., Hsieh-Li H.M., Jong Y.J., Wang N.M., Tsai C.H., and Li H. Treatment of spinal muscular atrophy by sodium butyrate. Proc. Natl. Acad. Sci. USA 98 (2001) 9808-9813
57. Brichta L., Hofmann Y., Hahnen E., Siebzehnrubl F.A., Raschke H., Blumcke I., Eyupoglu I.Y., and Wirth B. Valproic acid increases the SMN2 protein level: A well-known drug as a potential therapy for spinal muscular atrophy. Hum. Mol. Genet. 12 (2003) 2481-2489
58. Riessland M., Brichta L., Hahnen E., and Wirth B. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells. Hum. Genet. 120 (2006) 101-110
59. Nissim-Rafinia M., Aviram M., Randell S.H., Shushi L., Ozeri E., Chiba-Falek O., Eidelman O., Pollard H.B., Yankaskas J.R., and Kerem B. Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation. EMBO Rep. 5 (2004) 1071-1077
60. Buhler M., and Moazed D. Transcription and RNAi in heterochromatic gene silencing. Nat. Struct. Mol. Biol. 14 (2007) 1041-1048
61. Grewal S.I., and Elgin S.C. Transcription and RNA interference in the formation of heterochromatin. Nature 447 (2007) 399-406
62. Sims III R.J., Millhouse S., Chen C.F., Lewis B.A., Erdjument-Bromage H., Tempst P., Manley J.L., and Reinberg D. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol. Cell 28 (2007) 665-676